|
US5674839A
(en)
|
1987-05-22 |
1997-10-07 |
Competitive Technologies, Inc. |
Cyclic analogs of alpha-MSH fragments
|
|
EP0292291B1
(en)
|
1987-05-22 |
1994-08-10 |
University Patents, Inc. |
Linear and cyclic analogs of alpha-msh fragments with extraordinary potency
|
|
US5683981A
(en)
|
1987-05-22 |
1997-11-04 |
Competitive Technologies, Inc. |
Cyclic bridged analogs of α-MSH and methods thereof
|
|
US5192746A
(en)
|
1990-07-09 |
1993-03-09 |
Tanabe Seiyaku Co., Ltd. |
Cyclic cell adhesion modulation compounds
|
|
US6100048A
(en)
|
1992-04-10 |
2000-08-08 |
Oregon Health Sciences University |
Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals
|
|
WO1994022460A1
(en)
|
1993-04-05 |
1994-10-13 |
University Patents, Inc. |
Diagnosis and treatment of erectile dysfunction
|
|
US6054556A
(en)
|
1995-04-10 |
2000-04-25 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Melanocortin receptor antagonists and agonists
|
|
US5731408A
(en)
|
1995-04-10 |
1998-03-24 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Peptides having potent antagonist and agonist bioactivities at melanocortin receptors
|
|
US7396814B2
(en)
|
1995-06-07 |
2008-07-08 |
Palatin Technologies, Inc. |
Metallopeptide compositions for treatment of sexual dysfunction
|
|
CA2158425C
(en)
|
1995-09-15 |
2003-01-28 |
Mac E. Hadley |
Diagnostic and treatment of erectile dysfunction
|
|
IL118003A0
(en)
|
1996-04-23 |
1996-08-04 |
Yeda Res & Dev |
Novel vip fragments and pharmaceutical compositions comprising them
|
|
WO1998027113A2
(en)
|
1996-12-17 |
1998-06-25 |
Quadrant Holdings Cambridge Limited |
Melanocortin derivatives for specific binding of melanocortin receptor 3, 4 or 5
|
|
AU7464998A
(en)
|
1997-10-27 |
1999-05-17 |
Trega Biosciences, Inc. |
Melanocortin receptor ligands and methods of using same
|
|
US20020099003A1
(en)
|
1997-10-28 |
2002-07-25 |
Wilson Leland F. |
Treatment of female sexual dysfunction with vasoactive agents, particularly vasoactive intestinal polypeptide and agonists thereof
|
|
GB9808229D0
(en)
|
1998-04-17 |
1998-06-17 |
Quadrant Holdings Cambridge |
Melanocortin receptor ligands
|
|
US6284735B1
(en)
|
1998-04-28 |
2001-09-04 |
Lion Bioscience Ag |
HP-3228 and related peptides to treat sexual dysfunction
|
|
US6534503B1
(en)
|
1998-04-28 |
2003-03-18 |
Lion Bioscience Ag |
Melanocortin receptor-3 ligands to treat sexual dysfunction
|
|
SE9801571D0
(sv)
|
1998-05-05 |
1998-05-05 |
Wapharm Ab |
Melanokortin-1-receptorselektiva föreningar
|
|
SE9804614A0
(en)
|
1998-07-06 |
2000-01-07 |
A+ Science Invest Ab |
New peptides and use thereof
|
|
GB9816234D0
(en)
|
1998-07-24 |
1998-09-23 |
William Harvey Research Limite |
Compounds for use in the treatment of inflammation
|
|
GB9827500D0
(en)
|
1998-12-14 |
1999-02-10 |
Wapharm Ab |
Compounds for control of eating, growth and body weight
|
|
DE69930873T2
(de)
|
1998-12-23 |
2007-03-15 |
Merck & Co., Inc. |
Dna-moleküle kodierende spleissvarianten des humanen melanocortin-1-rezeptorproteins
|
|
US6887846B2
(en)
|
1999-03-24 |
2005-05-03 |
Zengen, Inc. |
Antimicrobial amino acid sequences derived from alpha-melanocyte-stimulating hormone
|
|
HK1044954B
(en)
|
1999-03-29 |
2008-11-21 |
The Procter & Gamble Company |
Melanocortin receptor ligands
|
|
CN1367792A
(zh)
*
|
1999-06-25 |
2002-09-04 |
研究及应用科学协会股份有限公司 |
促生长素抑制素激动剂
|
|
US6579968B1
(en)
|
1999-06-29 |
2003-06-17 |
Palatin Technologies, Inc. |
Compositions and methods for treatment of sexual dysfunction
|
|
US7235625B2
(en)
*
|
1999-06-29 |
2007-06-26 |
Palatin Technologies, Inc. |
Multiple agent therapy for sexual dysfunction
|
|
US7176279B2
(en)
*
|
2000-06-28 |
2007-02-13 |
Palatin Technologies, Inc. |
Cyclic peptide compositions and methods for treatment of sexual dysfunction
|
|
US6699873B1
(en)
|
1999-08-04 |
2004-03-02 |
Millennium Pharmaceuticals, Inc. |
Melanocortin-4 receptor binding compounds and methods of use thereof
|
|
US7049398B1
(en)
|
1999-08-12 |
2006-05-23 |
Palatin Technologies, Inc. |
Melanocortin metallopeptide constructs, combinatorial libraries and applications
|
|
WO2001030808A1
(en)
|
1999-10-27 |
2001-05-03 |
The Regents Of The University Of California |
Methods and compounds for modulating melanocortin receptor-ligand binding
|
|
US20030064921A1
(en)
|
1999-10-27 |
2003-04-03 |
The Regents Of The University Of California |
Methods and compounds for modulating melanocortin receptor ligand binding and activity
|
|
AU2001229491A1
(en)
*
|
2000-01-18 |
2001-07-31 |
Merck And Co., Inc. |
Cyclic peptides as potent and selective melanocortin-4 receptor antagonists
|
|
US6600015B2
(en)
|
2000-04-04 |
2003-07-29 |
Hoffmann-La Roche Inc. |
Selective linear peptides with melanocortin-4 receptor (MC4-R) agonist activity
|
|
AU2001261363A1
(en)
|
2000-05-09 |
2001-11-20 |
The Regents Of The University Of California |
Methods and compounds for modulating melanocortin receptor ligand binding and activity
|
|
GB0012370D0
(en)
|
2000-05-22 |
2000-07-12 |
Quadrant Holdings Cambridge |
Peptoids
|
|
PT1315750E
(pt)
|
2000-08-30 |
2007-05-31 |
Hoffmann La Roche |
Péptidos cíclicos com actividade agonista para o receptor 4 de melanocortina
|
|
HUP0303085A2
(hu)
|
2000-09-27 |
2003-12-29 |
The Procter & Gamble Co. |
Melanokortin receptor ligandumok és ezeket tartalmazó gyógyszerkészítmények
|
|
US20030113263A1
(en)
|
2001-02-13 |
2003-06-19 |
Oregon Health And Sciences University, A Non-Profit Organization |
Methods and reagents for using mammalian melanocortin receptor antagonists to treat cachexia
|
|
ITMI20011057A1
(it)
|
2001-05-22 |
2002-11-22 |
Bracco Imaging Spa |
Preparazione ed uso di peptidi ciclici e ramificati e loro deriati marcati come agenti terapeutici agonisti o antagonisti della colecistochi
|
|
US7345144B2
(en)
|
2001-07-11 |
2008-03-18 |
Palatin Technologies, Inc. |
Cyclic peptides for treatment of cachexia
|
|
US7342089B2
(en)
*
|
2001-07-11 |
2008-03-11 |
Palatin Technologies, Inc. |
Cyclic peptides for treatment for cachexia
|
|
AU2002322466B2
(en)
|
2001-07-11 |
2007-08-30 |
Palatin Technologies, Inc. |
Linear and cyclic melanocortin receptor-specific peptides
|
|
WO2003006604A2
(en)
|
2001-07-12 |
2003-01-23 |
Merck & Co., Inc. |
Cyclic peptides as potent and selective melanocortin-4 receptor agonists
|
|
WO2003013571A1
(en)
*
|
2001-08-10 |
2003-02-20 |
Palatin Technologies, Inc. |
Peptidomimetics of biologically active metallopeptides
|
|
FR2835528B1
(fr)
|
2002-02-01 |
2004-03-12 |
Inst Europ Biolog Cellulaire |
Nouveaux derives peptidiques, leur preparation et leur application therapeutique et cosmetique
|
|
US20030186249A1
(en)
|
2002-04-01 |
2003-10-02 |
Zairen Sun |
Human TARPP genes and polypeptides
|
|
US7034004B2
(en)
|
2002-05-07 |
2006-04-25 |
University Of Florida |
Peptides and methods for the control of obesity
|
|
AU2003248888A1
(en)
|
2002-07-09 |
2004-01-23 |
Palatin Technologies, Inc. |
Peptide composition for treatment of sexual dysfunction
|
|
US7135548B2
(en)
|
2002-11-14 |
2006-11-14 |
Zengen, Inc. |
Modified α-MSH peptides and derivatives thereof
|
|
US20060122121A1
(en)
|
2002-11-14 |
2006-06-08 |
Lipton James M |
Modified alpha-MSH peptides and derivatives thereof
|
|
KR20060026011A
(ko)
*
|
2003-05-09 |
2006-03-22 |
노보 노르디스크 에이/에스 |
비만 치료용 펩티드
|
|
AU2004235872A1
(en)
*
|
2003-05-09 |
2004-11-18 |
Novo Nordisk A/S |
Peptides for use in treating obesity
|
|
WO2005000338A1
(en)
|
2003-06-19 |
2005-01-06 |
Eli Lilly And Company |
Uses of melanocortin-3 receptor (mc3r) agonist peptides
|
|
EA200600055A1
(ru)
|
2003-06-19 |
2006-08-25 |
Эли Лилли Энд Компани |
Агонисты рецептора меланокортина 4 (мк4 ) и их применение
|
|
US7084111B2
(en)
|
2003-06-23 |
2006-08-01 |
University Of Florida Research Foundation, Inc. |
Melanocortin receptor templates, peptides, and use thereof
|
|
US20050026948A1
(en)
|
2003-07-29 |
2005-02-03 |
Boehringer Ingelheim International Gmbh |
Medicaments for inhalation comprising an anticholinergic and a betamimetic
|
|
ES2286679T3
(es)
|
2003-08-20 |
2007-12-01 |
Eli Lilly And Company |
Compuestos, procedimientos y formulaciones para la liberacion oral de un compuesto de peptido de tipo glucagon (glp)-1 o un peptido agonist a del receptor de melanocortina 4 (mc4).
|
|
JP2007532471A
(ja)
|
2003-09-30 |
2007-11-15 |
ノボ ノルディスク アクティーゼルスカブ |
新規メラノコルチンレセプターアゴニスト
|
|
TWI341835B
(en)
|
2003-11-12 |
2011-05-11 |
Lg Life Sciences Ltd |
Melanocortin receptor agonists
|
|
DK1689349T3
(da)
|
2003-11-24 |
2013-12-02 |
Clinuvel Pharmaceuticals Ltd |
Fremgangsmåde til induktion af melanogenese i mennesker med variante MC1R-alleler
|
|
WO2005060985A1
(en)
|
2003-12-10 |
2005-07-07 |
Merck & Co., Inc. |
Inhibition of voluntary ethanol consumption with selective melanocortin 4-receptor agonists
|
|
US8193310B2
(en)
*
|
2004-03-19 |
2012-06-05 |
The University Of Queensland |
Alpha helical mimics, their uses and methods for their production
|
|
EP1732586A1
(en)
|
2004-03-29 |
2006-12-20 |
Eli Lilly And Company |
Uses of melanocortin-4 receptor (mc4r) agonist peptides administered by continunous infusion
|
|
CN1563076A
(zh)
|
2004-04-02 |
2005-01-12 |
西南生物工程产业化中试基地有限公司 |
一种用于治疗性功能障碍的α－MSH类似物及制备方法
|
|
US7442693B2
(en)
|
2004-05-28 |
2008-10-28 |
Smithkline Beecham Corporation |
Diazepine compounds as ligands of the melanocortin 1 and/or 4 receptors
|
|
ES2566801T3
(es)
|
2004-08-04 |
2016-04-15 |
Clinuvel Pharmaceuticals Limited |
Métodos de inducción de melanogénesis en un sujeto
|
|
TW200626611A
(en)
|
2004-09-20 |
2006-08-01 |
Lonza Ag |
Peptide cyclisation
|
|
NZ554427A
(en)
|
2004-10-08 |
2010-09-30 |
Clinuvel Pharmaceuticals Ltd |
Compositions and methods for inducing melanogenesis in a subject utilising afamelanotide
|
|
DK1812046T3
(da)
|
2004-10-25 |
2011-06-06 |
Centocor Ortho Biotech Inc |
Melanocortinreceptor-bindende mimetilegemer, sammensætninger, fremgangsmåder og anvendelser
|
|
WO2006048450A2
(en)
|
2004-11-04 |
2006-05-11 |
Novo Nordisk A/S |
Peptides for use in the treating obesity
|
|
WO2006048452A2
(en)
|
2004-11-04 |
2006-05-11 |
Novo Nordisk A/S |
Peptides for use in treating of obesity
|
|
CN101052648A
(zh)
|
2004-11-04 |
2007-10-10 |
诺和诺德公司 |
用于治疗肥胖的新颖的肽类
|
|
US20080306008A1
(en)
|
2004-11-04 |
2008-12-11 |
Nova Nordisk A/S |
Peptides for Use in the Treatment of Obesity
|
|
WO2006060873A1
(en)
|
2004-12-09 |
2006-06-15 |
Prince Henry's Institute Of Medical Research |
Method for restoring reproductive function
|
|
WO2006073771A2
(en)
|
2005-01-05 |
2006-07-13 |
Eli Lilly And Company |
Polyethylene glycol linked mc4r or mc3r agonist peptides
|
|
WO2006076442A2
(en)
|
2005-01-14 |
2006-07-20 |
Janssen Pharmaceutica N.V. |
Triazolopyrimidine derivatives
|
|
WO2006097526A1
(en)
|
2005-03-17 |
2006-09-21 |
Novo Nordisk A/S |
Compounds for use in the treatment of obesity
|
|
CA2609951A1
(en)
|
2005-05-31 |
2006-12-07 |
Yissum Research Development Company Of The Hebrew University Of Jerusale M |
Backbone cyclized melanocortin stimulating hormone (.alpha.s) analogs
|
|
ES2663916T3
(es)
|
2005-07-08 |
2018-04-17 |
Ipsen Pharma |
Ligandos de los receptores de la melanocortina
|
|
EP1915168A4
(en)
|
2005-07-08 |
2010-03-31 |
Ipsen Pharma |
LIGANDS OF MELANOCORTIN RECEPTORS
|
|
CN1709906A
(zh)
|
2005-07-15 |
2005-12-21 |
中国科学技术大学 |
α－促黑激素的环状类似肽及其应用
|
|
CN101222942A
(zh)
|
2005-07-18 |
2008-07-16 |
诺沃-诺迪斯克有限公司 |
用于治疗肥胖的肽
|
|
ES2407107T3
(es)
|
2005-08-26 |
2013-06-11 |
Abbvie Inc. |
Análogos de alfa-MSH terapéuticamente activos
|
|
WO2007027574A2
(en)
|
2005-08-29 |
2007-03-08 |
Palatin Technologies, Inc. |
Cyclic peptide isolation by spray drying
|
|
WO2007035474A2
(en)
|
2005-09-15 |
2007-03-29 |
Novomed Technologies, Inc. (Shanghai) |
Transdermal delivery peptides and method of use thereof
|
|
US8114844B2
(en)
*
|
2006-03-30 |
2012-02-14 |
Palatin Technologies, Inc. |
Linear and cyclic melanocortin receptor-specific peptidomimetics
|
|
ZA200901365B
(en)
*
|
2006-08-28 |
2010-05-26 |
Clinuvel Pharmaceuticals Ltd |
Method for reducing incidence or rate of development of skin cancers and related conditions
|
|
EP2091914A4
(en)
|
2006-11-08 |
2010-12-29 |
Chongxi Yu |
TRANSDERMAL ADMINISTRATION SYSTEMS FOR PEPTIDES AND RELATED CONNECTIONS
|
|
US7879894B2
(en)
*
|
2006-11-28 |
2011-02-01 |
Warsaw Orthopedic, Inc. |
Use of anti-cytokine agents for treating carpal and tarsal tunnel syndrome
|
|
JP2010516654A
(ja)
|
2007-01-18 |
2010-05-20 |
ノボ・ノルデイスク・エー／エス |
肥満の治療に使用される新規ペプチド
|
|
US20100056433A1
(en)
|
2007-01-18 |
2010-03-04 |
Novo Nordisk A/S |
Novel Peptides for Use in the Treatment of Obesity
|
|
US20100016237A1
(en)
|
2007-01-18 |
2010-01-21 |
Novo Nordisk A/S |
Novel Peptides for Use in the Treatment of Obesity
|
|
US20100016238A1
(en)
|
2007-01-18 |
2010-01-21 |
Novo Nordisk A/S |
Peptides for Use in the Treatment of Obesity
|
|
US20100022446A1
(en)
|
2007-01-18 |
2010-01-28 |
Novo Nordisk A/S |
Use of Peptides in Combination with Surgical Intervention for the Treatment of Obesity
|
|
SI2125714T1
(sl)
|
2007-03-16 |
2011-10-28 |
Pfizer Ltd |
Hidrokloridna sol 5-(3-(3-hidroksifenoksi)azetidin-1-il)-5-metil-2,2-difenilheksanamida
|
|
FR2914646A1
(fr)
|
2007-04-04 |
2008-10-10 |
Neorphys Soc Par Actions Simpl |
Analogues peptidiques des recepteurs des melanocortines
|
|
EP2167112A4
(en)
*
|
2007-06-15 |
2012-01-25 |
Ipsen Pharma Sas |
CYCLIC PEPTIDE MELANOCORTIN RECEPTOR LIGANDS
|
|
US20100329996A1
(en)
|
2007-09-12 |
2010-12-30 |
Glaxo Group Limited |
Novel Combination of Therapeutic Agents
|
|
EP2979703B1
(en)
|
2007-11-05 |
2018-07-18 |
Ipsen Pharma S.A.S. |
Use of melanocortins to treat insulin sensitivity
|
|
AR072072A1
(es)
|
2008-06-09 |
2010-08-04 |
Palatin Technologies Inc |
Peptidos especificos del receptor de melanocortina para el tratamiento de la obesidad / 669
|
|
EP2300036B1
(en)
*
|
2008-06-09 |
2017-04-05 |
Palatin Technologies, Inc. |
Melanocortin receptor-specific peptides for treatment of sexual dysfunction
|
|
UY32690A
(es)
|
2009-06-08 |
2011-01-31 |
Astrazeneca Ab |
Péptidos específicos para receptores de melanocortina
|
|
WO2010144341A2
(en)
|
2009-06-08 |
2010-12-16 |
Palatin Technologies, Inc. |
Lactam-bridged melanocortin receptor-specific peptides
|
|
BRPI1009644B1
(pt)
*
|
2009-06-08 |
2022-02-08 |
Palatin Technologies, Inc |
Peptídeo cíclico ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica e uso da composição farmacêutica
|
|
AU2010321738B2
(en)
|
2009-11-23 |
2016-07-14 |
Palatin Technologies, Inc. |
Melanocortin-1 receptor-specific cyclic peptides
|
|
EP2504351A4
(en)
*
|
2009-11-23 |
2013-10-30 |
Palatin Technologies Inc |
MELANOCORTIN-1 RECEPTOR-SPECIFIC LINEAR PEPTIDE
|